Press Releases

Investor Alerts

Sep 17, 2019

Satsuma Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Sep 12, 2019

Satsuma Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock
Sep 3, 2019

Satsuma Pharmaceuticals Announces Poster Presentations at the International Headache Congress
Sep 3, 2019

Satsuma Pharmaceuticals, Inc. Announces Proposed Initial Public Offering of Common Stock
Aug 22, 2019

Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine

Show per page